Egr-1, PKC Beta, Signalling and Atherosclerosis
Egr-1, PKC Beta, Signalling and Atherosclerosis
批准号:
7006966
负责人:
SHI FANG YAN
金额:
$35.37万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-01-15 至 2008-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The immediate early gene, early growth response-1 (egr-1), is linked to maladaptive host response mechanisms m settings of acute cellular perturbation. In addition to acute stress, up regulation of egr-1 may be linked to chronic vascular stress. Transcripts for egr-1 were up regulated in both human and murine atherosclerotic lesions compared to adjacent non-atheromatous plaque, thereby suggesting that the impact of egr-1 in vascular stress might not be limited to the acute setting, rather that egr-1 might impact on chronic vascular perturbation, such as atherosclerosis. Our preliminary studies support this concept, as real time PCR revealed a time-dependent .increase in egr-1 transcripts in aortae of apo E (0) mice versus C57BL/6 controls at ages 6, 8, 10, 14 & 24 weeks. Immunohistochemistry demonstrated that the principal egr-1 expressing cells in atheromata were mononuclear phagocytes (MP) and smooth muscle cells (SMC). Homozygous egr-1 (0) mice in the apolipoprotein E (apo E) (0) background displayed significantly reduced atherosclerosis at the aortic root compared with apo E (0) animals at 14 or 24 weeks of age. In parallel, transcripts for proinflammatory & procoagulant mediators such as JE/MCP- 1, IL-1beta, VCAM-1, ICAM-1, tissue factor (TF) and PAI-1 were significantly diminished in double (0) mice versus mice solely deficient in apo E (0). To test if the PKCbeta axis, a key upstream regulator of egr-1 in acute hypoxia, modulated regulation of egr-1 in chronic vascular stress, we bred homozygous PKCbeta (0) mice into the apo E (0) background. A striking decrease in atherosclerotic lesion area was evident at age 24 weeks in PKCbeta (0)/apo E (0) vs apo E (0) mice. Levels of plasma glucose and cholesterol/triglyceride did not differ between egr- 1 (0)- or PKCbeta (0)/apo E (0) mice versus apo E (0) animals, thus implicating egr-1 and PKCbeta as distinct facets in atherosclerosis. We hypothesize that PKCbeta-dependent up regulation of egr-1 contributes importantly to acceleration of proinflammatory and prothrombotic mechanisms in the vessel wall; processes linked to the pathogenesis of atherosclerosis. We propose to dissect the biochemical and signaling mechanisms by which PKCbeta and egr-1 contribute to lesion development/progression in hypercholesterolemic apo E (0) mice and anticipate that elucidation of the mechanisms by which these factors impact on atherogenesis may highlight new targets for therapeutic intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RAGE, mitochondria, and tau pathology in AD
-
批准号:10532703
-
项目类别:
-
资助金额:$59.42万
-
财政年份:2019
-
负责人:SHI FANG YAN
-
依托单位:
RAGE, mitochondria, and tau pathology in AD
-
批准号:10320076
-
项目类别:
-
资助金额:$59.42万
-
财政年份:2019
-
负责人:SHI FANG YAN
-
依托单位:
PINK1 signaling and synaptic mitochondria integrity in AD
-
批准号:10091121
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2018
-
负责人:SHI FANG YAN
-
依托单位:
Egr-1, PKC Beta, Signalling and Atherosclerosis
-
批准号:7162602
-
项目类别:
-
资助金额:$34.35万
-
财政年份:2005
-
负责人:SHI FANG YAN
-
依托单位:
Egr-1, PKC Beta, Signalling and Atherosclerosis
-
批准号:7330488
-
项目类别:
-
资助金额:$34.35万
-
财政年份:2005
-
负责人:SHI FANG YAN
-
依托单位:
Egr-1, PKC Beta, Signalling and Atherosclerosis
-
批准号:6867116
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2005
-
负责人:SHI FANG YAN
-
依托单位:
Egr-1, PKC Beta, Signalling and Atherosclerosis
-
批准号:7568212
-
项目类别:
-
资助金额:$34.35万
-
财政年份:2005
-
负责人:SHI FANG YAN
-
依托单位:
Early Growth Response-1 (Egr-1), PKC Beta and Restenosis
-
批准号:7078584
-
项目类别:
-
资助金额:$31.93万
-
财政年份:2004
-
负责人:SHI FANG YAN
-
依托单位:
Early Growth Response-1 (Egr-1), PKC Beta and Restenosis
-
批准号:6894666
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2004
-
负责人:SHI FANG YAN
-
依托单位:
Early Growth Response-1 (Egr-1), PKC Beta and Restenosis
-
批准号:6822517
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2004
-
负责人:SHI FANG YAN
-
依托单位:
Early Growth Response-1 (Egr-1), PKC Beta and Restenosis
-
批准号:7234002
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2004
-
负责人:SHI FANG YAN
-
依托单位:
Mouse Breeding and Procedure Core
-
批准号:8181500
-
项目类别:
-
资助金额:$31.98万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
AR & AGE-RAGE IN AGING: IMPACT ON ENDOTHELIAL AND VASCULAR STRESS
-
批准号:7796546
-
项目类别:
-
资助金额:$20.9万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
AR & AGE-RAGE IN AGING: IMPACT ON ENDOTHELIAL AND VASCULAR STRESS
-
批准号:8042640
-
项目类别:
-
资助金额:$21.31万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
TRANSGENIC MOUSE AND ANIMAL MANAGEMENT
-
批准号:8378067
-
项目类别:
-
资助金额:$52.42万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
RAGE and the host response to hypoxic stress
-
批准号:8378280
-
项目类别:
-
资助金额:$23.8万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
Mouse Breeding and Procedure Core
-
批准号:8586333
-
项目类别:
-
资助金额:$32.92万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
TRANSGENIC MOUSE AND ANIMAL MANAGEMENT
-
批准号:8235877
-
项目类别:
-
资助金额:$51.93万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
Mouse Breeding and Procedure Core
-
批准号:8976283
-
项目类别:
-
资助金额:$33.54万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
RAGE and the host response to hypoxic stress
-
批准号:8181491
-
项目类别:
-
资助金额:$23.92万
-
财政年份:--
-
负责人:SHI FANG YAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
疏肝补肾毓麟汤通过激活EP1/PKC/Nrf2通路抑制铁死亡改善少弱精子症的机制研究
-
批准号:JCZRLH202601317
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
铁蛋白磷酸化通过氧化应激-ROS/PKC轴调控亚细胞定位逆转卵巢癌耐药的机制研究
-
批准号:JCZRLH202601670
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
pH/ROS双响应Fe3O4-NP激活 PKCβ2/ACSL4抑制支架内再狭窄的作用及机制研究
-
批准号:2026JJ81986
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:段景锋
-
依托单位:
PKCδ/EGR1/PHGDH 轴调控丝氨酸代谢促进内皮细胞衰老在糖尿病创面血管新生障碍中的机制研究
-
批准号:JCZRQNB202600620
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
钩吻素子通过GlyR调控PKC/NLRP3介导的巨噬细胞焦亡以减轻急性肺损伤的机制研究
-
批准号:2026JJ60021
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:徐小庆
-
依托单位:
肿瘤相关成纤维细胞调控SPP1/ PKCα介导铁死亡在宫颈癌化疗耐药中的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:胡雪媚
-
依托单位:
PKC γ通过调节线粒体蛋白的磷酸化减轻脑缺血再灌注损伤的实验研究
-
批准号:2025JJ50618
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:曾六旺
-
依托单位:
基于F/IGF1R/PKC ζ 通路研究夏枯草中
Mesonolic acid B抑制RSV感染性肺炎的
作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:唐维
-
依托单位:
基于TAAR1-PKC-CRF信号通路探究肠道菌群代谢产物苯乙胺在腹泻型肠易激综合征发病中的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:蔡力
-
依托单位:
基于5-HT–[Ca2+]i–PKC信号通路研究葎草制剂通过改善炎症诱导的内质网应激和间隙连接抑制促进糖尿病足创口愈合的机制
-
批准号:JCZRLH202501287
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位: